发明名称 Sn-2-monoacylgycerols and lipid malabsorption
摘要 The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising a sn-2 monoacylglycerol derivative, wherein the sn-1 and sn-3 positions are blocked by protective groups. The acyl group may be a fatty acid, for example one with anti-inflammatory properties.
申请公布号 US9522132(B2) 申请公布日期 2016.12.20
申请号 US201514686340 申请日期 2015.04.14
申请人 Nestec S.A. 发明人 Bistrian Bruce;Destaillats Frederic;Cruz-Hernandez Cristina;Dionisi Fabiola;Masserey-Elmelegy Isabelle;Oliveira Manuel;Moulin Julie Celine
分类号 A01N43/02;A61K31/335;A61K31/357;A23L1/30;A61K31/202;A61K31/232 主分类号 A01N43/02
代理机构 K&L Gates LLP 代理人 K&L Gates LLP
主权项 1. A method for lowering an inflammation response in an individual having multiple sclerosis and a condition selected from the group consisting of lipid maldigestion, lipid malabsorption, and a combination thereof, the method comprising: administering a composition comprising sn-2 monoacylglycerol, wherein the sn-1 and sn-3 positions are blocked by protective groups and the acyl group is a fatty acid having anti-inflammatory properties selected from the group consisting of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), α-linolenic acid (ALA), stearidonic acid (SA), γ-linolenic acid (GLA), dihomo-γ-linolenic acid (DGLA), n-3 docosapentanenoic acid (DPA), sciadonic acid and juniperonic acid, to an individual in need of same.
地址 Vevey CH